RxDoctor Payments Data

Marsha Miller

Gerontology · New Haven, CTNPI 1306259296

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations.

$2,301in general payments, 2019–2025

Across 99 payments — averaging $23.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$453
  • Merck$349
  • Novartis$277
  • AstraZeneca$230
  • Novo Nordisk$165
  • E.r. Squibb & Sons, L.L.C.$162
  • plus $666 from 13 others

What the payments were for

  • Food & beverage$2,28099%
  • Education$221%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,301 in reported general payments places this provider in the 85th percentile of 90 gerontology providers in Connecticut.

See all gerontology providers in Connecticut

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban65$100,125
XareltoRivaroxaban32$41,535
EntrestoSacubitril/Valsartan23$31,726
FarxigaDapagliflozin Propanediol19$29,324
BrilintaTicagrelor30$29,199
Ranolazine ErRanolazine23$7,474
Nebivolol Hcl69$5,350
Rosuvastatin Calcium232$2,160
Olmesartan Medoxomil110$2,027
Metoprolol Succinate158$1,821
Valsartan87$1,495
Atorvastatin Calcium117$783
Amlodipine Besylate118$634
Lisinopril51$416
Losartan Potassium62$401

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$453$100,12565 claims
AstraZenecaFarxiga, Brilinta$230$58,52349 claims
Johnson & JohnsonXarelto$80$41,53532 claims
NovartisEntresto$277$31,72623 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 90 gerontology providers in Connecticut.

Other gerontology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →